COMBIFOR

1- Asthma: Combifor is indicated for the continuous treatment of persistent asthma, in situations where the inhaled administration of a drug combining a corticosteroid and a long-acting beta-2 agonist bronchodilator is justified: - in patients inadequately controlled by inhaled corticosteroid therapy and taking a short-acting beta-2 agonist bronchodilator by inhalation on demand or - in patients controlled by administration of inhaled corticosteroid therapy in combination with continuous treatment with long-acting inhaled beta-2 agonist.

2- Chronic obstructive pulmonary disease (COPD) Symptomatic treatment of severe COPD (FEV <50% of the theoretical value) in patients with a history of repeated exacerbations and significant symptoms despite continuous treatment with a long-acting bronchodilator .